Le Lézard
Classified in: Environment, Health, Science and technology
Subjects: NPT, SVY, ENI

GLOBAL SURVEY IDENTIFIES COST OF LIVING, LONELINESS, TECHNOLOGY, CLIMATE CONCERNS DEEPENING


Global poll sampling 50,000 people from 23 countries highlights increasing discontent across a range of issues

RIYADH, Saudi Arabia, Oct. 26, 2023 /PRNewswire/ -- A global survey commissioned by non-profit Future Investment Initiative (FII) Institute, in partnership with Accenture is released today. It identifies predominant issues of concern to citizens across the world. 

 

GLOBAL SURVEY IDENTIFIES COST OF LIVING, LONELINESS, TECHNOLOGY, CLIMATE CONCERNS DEEPENING

 

The survey, known as the FII PRIORITY Compass, is an annual research exercise which polls individuals from a range of ages, backgrounds and countries, informing policy development and providing data for leaders, CEOs, policy makers, and organizations to identify with accuracy the sentiments of 60% of the world's population.

The data plays a vital role in shaping year-round discussions, policy advisory, and investment decisions at the FII Institute. The institute is dedicated to addressing common issues facing humanity, such as economic growth, prosperity, climate change, technology regulation and equitable access to healthcare and education.

This year's FII PRIORITY Compass report identifies several key issues, common to communities across the world:

At the FII7 summit currently underway in Riyadh (24 -26 October) 6,000 leaders, investors, experts, academics and innovators are taking part in over 200 panels and discussions designed to tackle the big issues facing humanity. This research will inform these discussions by providing essential insights into the actual issues that impact everyday people.

FII7 happens one month after world leaders gathered in New York for the United Nations General Assembly (UNGA) and six weeks after G20 leaders met in New Delhi. It happens four weeks before world leaders gather to discuss climate action at COP28.

Richard Attias, CEO of the Future Investment Initiative Institute, says:

"The 50,000 people we surveyed in 23 countries give us unparalleled insights into what matters to humanity. We will now investigate everything that we are hearing. At FII7 next week our data-driven agenda will help formulate initiatives and develop resolutions for action. With many of the world's leaders and biggest investors in the room we can play our part in shaping a better and safer world."

About FII Institute

The Future Investment Initiative (FII) Institute is a global nonprofit foundation driven by data with an investment arm and one agenda: Impact on Humanity. Global and inclusive, we foster great minds from around the world and turn ideas into real-world solutions in four critical areas: Artificial Intelligence (AI) & Robotics, Education, Healthcare and Sustainability.

Photo - https://mma.prnewswire.com/media/2258667/Future_Investment_Initiative_Institute.jpg
Logo - https://mma.prnewswire.com/media/1811613/4361795/FII_Institute_Logo.jpg

 

(PRNewsfoto/FII Institute)

 

SOURCE Future Investment Initiative Institute


These press releases may also interest you

at 08:05
GE HealthCare today unveiled SIGNA MAGNUS, an FDA 510(k) pending head-only magnetic resonance (MR) scanner designed to explore advancements in neuroscience, which have been restricted by the performance limitations of conventional whole-body MR...

at 07:00
To mark National Hospice Palliative Care Week, the Quebec Coalition for Palliative Care Access (the Coalition) is proud to celebrate the positive impact of palliative care on the well-being of people with life-limiting illness. Palliative care is...

at 06:00
A native born and trained Brazilian oncologist is in the forefront of a new era in the treatment of cancer patients with cutting edge proton therapy medical technology developed in Israel by P-Cure. "It is my dream to be able to bring the P-Cure...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...

4 mai 2024
Women's Heart Health Month is recognized every May and is focused on raising awareness about cardiovascular health among women. It aims to educate women about the risks, symptoms, and prevention of heart disease, which is the leading cause of death...



News published on and distributed by: